Stocks and Investing Stocks and Investing
Thu, July 18, 2024

Jason Gerberry Maintained (AXSM) at Hold with Decreased Target to $95 on, Jul 18th, 2024


Published on 2024-10-28 12:33:04 - WOPRAI, Jason Gerberry
  Print publication without navigation


Jason Gerberry of B of A Securities, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Decreased Target from $97 to $95 on, Jul 18th, 2024.

Jason has made no other calls on AXSM in the last 4 months.



There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 0 agree with Jason's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Jason


  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $106 on, Wednesday, June 12th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $190 on, Thursday, June 6th, 2024
  • Leonid Timashev of "RBC Capital" Maintained at Buy with Increased Target to $130 on, Wednesday, June 5th, 2024
  • Joel Beatty of "Baird" Maintained at Buy with Increased Target to $112 on, Tuesday, May 7th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 7th, 2024
  • Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $115 on, Monday, April 29th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $107 on, Wednesday, April 10th, 2024
  • Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
Contributing Sources